Skip to main content

Lung Density Analysis™ - Inspiration

Automated detection of potential Emphysema

LDAi provides fully-automated detection, visualization and quantification of areas of low attenuation (LAA) which can be indicative of emphysema. LDAi is validated for use with low-dose CT scans as a component of lung cancer screening programs and includes a patient-centered LungMap™ report to assist with smoking cessation counseling. LDAi provides results based on a standard inspiratory chest CT.

FDA 510(k) Cleared, CE Mark Certified, Health Canada Approved

The Power of Personalized Quantitative Imaging

With LDAi, descriptive terminology such as ‘mild’ or ‘moderate’ is no longer acceptable to accurately assess COPD or emphysema.

Rapid, Automated Inspiration-only Processing
The lungs are segmented from background tissue, and a user-configurable threshold allows detailed regional analysis of the CT density.
LDAi Physician Summary Report
Every configurable report includes: key slice visualization, percent of lung with density below -950 HU indicative of emphysema, overall lung volumes and density distribution/Perc15 Histogram
LDAi LungMap™ Report
Simple yet powerful and customizable visual for physicians and nurse navigators to discuss smoking cessation with their patients.
Complete Lobar Segmentations
LDAi’s segmentation algorithm consistently performs and can provide fissure integrity scores in custom applications

For Your Practice

LDAi is a fully automated solution delivering quantitative analysis and 3D visualization to the patient study in PACS. LDAi includes Imbio Noise Reduction Technology (NRT) to aid quantification and visualization of low dose scans, and also includes Imbio’s Patient LungMap™ report to aid smoking cessation counseling.

Suggested use cases for LDAi

  • Lung Cancer Screening programs and smoking cessation counseling
  • Population screening for emphysema/COPD on all chest CT scans
  • Patient selection for endobronchial valves
  • Lung Health Programs
  • Clinical Trials